MaxCyte, Inc. (NASDAQ:MXCT) Q4 2025 Earnings Call Transcript
Operator: Good day, everyone, and welcome to MaxCyte, Inc.’s fourth quarter earnings conference call. At this time, all participants are in a listen-only mode.
Maxcyte Inc. (MXCT)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Cadian Capital Eric Bannasch | 3,683,052 | $5,708,731 | -56% | 0.41% |
| 2. | Citadel Investment Group Ken Griffin | 1,488,818 | $2,307,668 | +86% | 0% |
| 3. | Millennium Management Israel Englander | 1,292,773 | $2,003,798 | +1083% | 0% |
| 4. | Renaissance Technologies Jim Simons | 786,900 | $1,219,695 | +5% | 0% |
| 5. | D E Shaw D. E. Shaw | 663,956 | $1,029,132 | +124% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.29 | 50,000 | $64,500.00 | 161,811 | 2025-08-13 | Filing | |
| $1.37 | 75,000 | $102,915.00 | 175,000 | 2025-08-13 | Filing | |
| $1.37 | 100,000 | $137,220.00 | 398,328 | 2025-08-13 | Filing | |
| $1.39 | 80,000 | $111,040.00 | 230,577 | 2025-08-13 | Filing | |
| $1.29 | 50,000 | $64,500.00 | 150,879 | 2025-08-13 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.82 | 10,142 | $8,265.73 | 151,669 | 2026-03-17 | Filing | |
| $2.09 | 10,684 | $22,377.64 | 39,893 | 2025-06-25 | Filing | |
| $3.18 | 1,211 | $3,850.13 | 59,439 | 2025-03-18 | Filing | |
| $3.18 | 353 | $1,122.29 | 64,219 | 2025-03-18 | Filing | |
| $3.18 | 6,939 | $22,061.16 | 111,811 | 2025-03-18 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 284,024 | $199,527 | 0.11% |
News See All
MaxCyte (MXCT) Launches ExPERT DTx Platform to Accelerate High-Throughput Drug Discovery
MaxCyte Inc. (NASDAQ:MXCT) is one of the best penny stocks under $1 to buy right now.
13 Best Penny Stocks Under $1 to Buy Right Now
Earlier on January 8, Royce Investment Partners co-chief investment officer Francis Gannon appeared on Yahoo Finance's 'Market Domination Overtime' to suggest that it is time for investors to get on board...
MaxCyte, Inc. (NASDAQ:MXCT) Q3 2025 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the MaxCyte Third Quarter Earnings Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded.
MaxCyte (MXCT) Signed a Strategic Platform License with Adicet Bio
MaxCyte, Inc. (NASDAQ:MXCT) is one of the Best 52-Week Low Penny Stocks to Buy Now. On August 4, MaxCyte, Inc. (NASDAQ:MXCT) announced signing a strategic platform license with Adicet Bio, Inc.
10 Best 52-Week Low Penny Stocks to Buy Now
On March 26, Gabelli released its Small Cap Outlook for 2025 and beyond.
MaxCyte, Inc. (NASDAQ:MXCT) Q2 2025 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the MaxCyte Second Quarter Earnings Conference Call. [Operator Instructions] Today's conference is being recorded.
MaxCyte, Inc. (MXCT): A Bull Case Theory
We came across a bullish thesis on MaxCyte, Inc. (MXCT) on Substack by OppCost. In this article, we will summarize the bulls’ thesis on MXCT. MaxCyte, Inc.
MaxCyte, Inc. (NASDAQ:MXCT) Q1 2025 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to the MaxCyte First Quarter Earnings Conference Call. At this time, all participants are in a listen-only mode.
MaxCyte, Inc. (NASDAQ:MXCT) Q4 2024 Earnings Call Transcript
Operator: Thank you for standing by and welcome to MaxCyte's Fourth Quarter Earnings Conference Call. At this time, all participants are in a listen-only mode.
Hedge Fund Resource Center